NDC 51862-604

LEXETTE

Halobetasol Propionate

LEXETTE is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Mayne Pharma. The primary component is Halobetasol Propionate.

Product ID51862-604_45387006-b38d-4423-b18f-4f815fad61e7
NDC51862-604
Product TypeHuman Prescription Drug
Proprietary NameLEXETTE
Generic NameHalobetasol Propionate
Dosage FormAerosol, Foam
Route of AdministrationTOPICAL
Marketing Start Date2019-04-23
Marketing CategoryNDA / NDA
Application NumberNDA210566
Labeler NameMayne Pharma
Substance NameHALOBETASOL PROPIONATE
Active Ingredient Strength1 mg/g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 51862-604-02

2 CANISTER in 1 CARTON (51862-604-02) > 50 g in 1 CANISTER
Marketing Start Date2019-04-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51862-604-33 [51862060433]

LEXETTE AEROSOL, FOAM
Marketing CategoryNDA
Application NumberNDA210566
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-23

NDC 51862-604-50 [51862060450]

LEXETTE AEROSOL, FOAM
Marketing CategoryNDA
Application NumberNDA210566
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-04-23

NDC 51862-604-02 [51862060402]

LEXETTE AEROSOL, FOAM
Marketing CategoryNDA
Application NumberNDA210566
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-04-23

Drug Details

Active Ingredients

IngredientStrength
HALOBETASOL PROPIONATE.5 mg/g

OpenFDA Data

SPL SET ID:d5d0d307-37ad-4714-ba3f-5343672bc0e7
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

NDC Crossover Matching brand name "LEXETTE" or generic name "Halobetasol Propionate"

NDCBrand NameGeneric Name
51862-604LEXETTEHalobetasol propionate
0187-0002Bryhalihalobetasol propionate
0168-0355Halobetasol Propionatehalobetasol propionate
0168-0356Halobetasol Propionatehalobetasol propionate
0713-0339Halobetasol PropionateHalobetasol Propionate
0713-0639Halobetasol PropionateHalobetasol Propionate
0713-0640Halobetasol PropionateHalobetasol Propionate
0713-0758Halobetasol PropionateHalobetasol Propionate
42254-250Halobetasol PropionateHalobetasol Propionate
45802-129Halobetasol PropionateHalobetasol Propionate
45802-131Halobetasol PropionateHalobetasol Propionate
51672-1321Halobetasol PropionateHalobetasol Propionate
51672-1322Halobetasol PropionateHalobetasol Propionate
51862-606Halobetasol propionateHalobetasol propionate
52565-073Halobetasol Propionatehalobetasol propionate
52959-961Halobetasol PropionateHalobetasol Propionate
55337-606Halobetasol propionateHalobetasol propionate
63629-8664Halobetasol PropionateHalobetasol Propionate
10631-102Ultravatehalobetasol propionate
10631-103Ultravatehalobetasol propionate
10631-122Ultravatehalobetasol propionate
10631-119Ultravate XHalobetasol Propionate
10631-121Ultravate XHalobetasol Propionate

Trademark Results [LEXETTE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LEXETTE
LEXETTE
88067259 not registered Live/Pending
Mayne Pharma LLC
2018-08-06
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.